Published on 28 May 2024 on Simply Wall St. via Yahoo Finance
Integra LifeSciences Holdings Corporation (NASDAQ:IART), is not the largest company out there, but it saw a significant share price rise of 22% in the past couple of months on the NASDAQGS. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let’s take a look at Integra LifeSciences Holdings’s outlook and value based on the most recent financial data to see if the opportunity still exists.
See our latest analysis for Integra LifeSciences Holdings
Is Integra LifeSciences Holdings Still Cheap?